Pesquisas alternativas:
doses develop » loss develop (Expandir a Pesquisa), posters develop (Expandir a Pesquisa), models develop (Expandir a Pesquisa)
develop type » developing type (Expandir a Pesquisa)
drug doses » drug disease (Expandir a Pesquisa)
drug dose » drug dosage (Expandir a Pesquisa)
doses develop » loss develop (Expandir a Pesquisa), posters develop (Expandir a Pesquisa), models develop (Expandir a Pesquisa)
develop type » developing type (Expandir a Pesquisa)
drug doses » drug disease (Expandir a Pesquisa)
drug dose » drug dosage (Expandir a Pesquisa)
1
“... delay and clonogenic cell survival during repeated drug treatment. A slow rate of resistance development...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
2
Por Yuan, Mingjun, Chua, Song Lin, Liu, Yang, Drautz-Moses, Daniela I, Yam, Joey Kuok Hoong, Aung, Thet Tun, Beuerman, Roger W, Salido, May Margarette Santillan, Schuster, Stephan C, Tan, Choon-Hong, Givskov, Michael, Yang, Liang, Nielsen, Thomas E
Publicado no Beilstein J Org Chem (2018)
“... with DNA replication in P. aeruginosa. Cisplatin treatment significantly repressed the type III secretion...”Publicado no Beilstein J Org Chem (2018)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
3
“... dependent on the drug’s pharmacological action and dose. Common Type B reactions seen in clinical practice...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
4
Por Hoffman-Luca, C. Gianna, Yang, Chao-Yie, Lu, Jianfeng, Ziazadeh, Daniel, McEachern, Donna, Debussche, Laurent, Wang, Shaomeng
Publicado no PLoS One (2015)
“... an amplified MDM2 gene and wild-type p53, we have investigated the acquired resistance mechanisms both in vitro...”Publicado no PLoS One (2015)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
5
Por Zhang, Weiguo, Gao, Chen, Konopleva, Marina, Chen, Ye, Jacamo, Rodrigo O., Borthakur, Gautam, Cortes, Jorge E., Ravandi, Farhad, Ramachandran, Abhijit, Andreeff, Michael
Publicado em 2014
“... to increasing doses of sorafenib, and in FLT3 ITD mutated AML patients, who developed relapse following...”Publicado em 2014
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
6
Por Bhattacharya, Sudin, Shoda, Lisl K.M., Zhang, Qiang, Woods, Courtney G., Howell, Brett A., Siler, Scott Q., Woodhead, Jeffrey L., Yang, Yuching, McMullen, Patrick, Watkins, Paul B., Andersen, Melvin E.
Publicado em 2012
“... of chemical- and drug-induced toxicity. The concept of “toxicity pathways” is described in the context...”Publicado em 2012
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
7
8
Por Carrington, Emma M., McKenzie, Mark D., Jansen, Elisa, Myers, Michelle, Fynch, Stacey, Kos, Cameron, Strasser, Andreas, Kay, Thomas W., Scott, Clare L., Allison, Janette
Publicado em 2009
“...-cells developed but were abnormally sensitive to apoptosis induced in vivo by low-dose STZ. Although a...”Publicado em 2009
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
9
Por Ono, Suzane Kioko, Kato, Naoya, Shiratori, Yasushi, Kato, Jun, Goto, Tadashi, Schinazi, Raymond F., Carrilho, Flair José, Omata, Masao
Publicado em 2001
“...After receiving lamivudine for 3 years to treat chronic hepatitis B, 67–75% of patients develop B...”Publicado em 2001
Obter o texto integral
Obter o texto integral
Artigo
10
Por Mizuarai Shinji, Yamanaka Kazunori, Itadani Hiraku, Arai Tsuyoshi, Nishibata Toshihide, Hirai Hiroshi, Kotani Hidehito
Publicado em 2009-06-01
“... small molecule inhibitor significantly enhances the anti-tumor efficacy of DNA damaging agents...”Publicado em 2009-06-01
Obter o texto integral
Artigo
11
Por Mizuarai, Shinji, Yamanaka, Kazunori, Itadani, Hiraku, Arai, Tsuyoshi, Nishibata, Toshihide, Hirai, Hiroshi, Kotani, Hidehito
Publicado em 2009
“... significantly enhances the anti-tumor efficacy of DNA damaging agents, specifically in p53 negative tumors...”Publicado em 2009
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
12
“..., antioxidation, drug metabolism, DNA repair and cell proliferation. It remains unclear whether the process...”
Obter o texto integral
Obter o texto integral
Artigo
13
“..., antioxidation, drug metabolism, DNA repair and cell proliferation. It remains unclear whether the process...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
14
Por Valianatos, Georgios, Valcikova, Barbora, Growkova, Katerina, Verlande, Amandine, Mlcochova, Jitka, Radova, Lenka, Stetkova, Monika, Vyhnakova, Michaela, Slaby, Ondrej, Uldrijan, Stjepan
Publicado no PLoS One (2017)
“... wild type p53-dependent transcription in A375 melanoma without causing significant DNA damage...”Publicado no PLoS One (2017)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
15
Por Smee, Donald F., Sidwell, Robert W., Kefauver, Debbie, Bray, Mike, Huggins, John W.
Publicado em 2002
“..., the drug prevented mortality in 80 to 100% of the mice treated with a single 100-mg/kg dose at 1, 2, 3...”Publicado em 2002
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
16
“... for systemic adenovirus infections rely on a nonhuman adenovirus. We established mouse adenovirus type 1 (MAV-1...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
17
Por Rabaaoui, Samira, Zouhiri, Fatima, Lançon, Agnès, Leh, Hervé, d'Angelo, Jean, Wattel, Eric
Publicado em 2008
“...The replication of the retrovirus human T-cell leukemia virus type 1 (HTLV-1) is linked...”Publicado em 2008
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
18
19
Por Hauser, Andrea, Mugenyi, Kizito, Kabasinguzi, Rose, Bluethgen, Kerstin, Kuecherer, Claudia, Harms, Gundel, Kunz, Andrea
Publicado em 2009
“... single-dose nevirapine. Lower detection limits of drug-resistant HIV type 1 (HIV-1) variants carrying...”Publicado em 2009
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
20
Por Huang, Sheng-Xiong, Feng, Zhiyang, Wang, Liyan, Galm, Ute, Wendt-Pienkowski, Evelyn, Yang, Dong, Tao, Meifeng, Coughlin, Jane M, Duan, Yanwen, Shen, Ben
Publicado em 2012
“... population. There have been continued efforts to develop new BLM analogues in the search for anticancer drugs...”Publicado em 2012
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo